# AbCellera
> AbCellera is a technology company that uses an integrated platform combining biology, computation, and engineering to develop antibody-based medicines from target identification to clinical trials. They have a pipeline of discovery programs across various therapeutic areas like endocrinology, immunology, autoimmunity, and oncology.
- URL: https://optimly.ai/brand/abcellera
- Logo: https://logo.clearbit.com/https://www.abcellera.com/
- Slug: abcellera
- BAI Score: 52/100
- Archetype: Challenger
- Category: Biotechnology
- Last Analyzed: July 15, 2026
## Buyer Intent Signals
Problems: Traditional Antibody Discovery: Relying on older, more time-consuming, and labor-intensive methods for antibody discovery and optimization, which often lack the integrated computational and engineerin | Contract Research Organizations (CROs): Outsourcing specific stages of drug discovery and development (e.g., hit identification, preclinical testing) to specialized CROs, rather than using a single, i | In-house R&D without Advanced Platform: Maintaining an in-house drug discovery program without adopting advanced integrated platforms, potentially leading to slower development cycles and higher costs
Solutions: AbCellera antibody discovery platform | AbCellera drug pipeline | AbCellera careers Vancouver | Specialized Computational Biology Software: Using individual software tools for specific aspects like protein modeling or sequence analysis, but lacking AbCellera's integrated biological and engineeri
---
## Full Details / RAG Data
### Overview
AbCellera is listed in the AI Directory.
AbCellera is a technology company that uses an integrated platform combining biology, computation, and engineering to develop antibody-based medicines from target identification to clinical trials. They have a pipeline of discovery programs across various therapeutic areas like endocrinology, immunology, autoimmunity, and oncology.
### Metadata
| Field        | Value |
|--------------|-------|
| Name         | AbCellera |
| Slug         | abcellera |
| URL          | https://optimly.ai/brand/abcellera |
| Logo         | https://logo.clearbit.com/https://www.abcellera.com/ |
| BAI Score    | 52/100 |
| Archetype    | Challenger |
| Category     | Biotechnology |
| Last Analyzed | July 15, 2026 |
| Last Updated | 2026-07-15T10:04:36.104Z |
### Verified Facts
- Founded: 2012
- Headquarters: Vancouver, Canada
### Buyer Intent Signals
#### Problems this brand solves
- Traditional Antibody Discovery: Relying on older, more time-consuming, and labor-intensive methods for antibody discovery and optimization, which often lack the integrated computational and engineerin
- Contract Research Organizations (CROs): Outsourcing specific stages of drug discovery and development (e.g., hit identification, preclinical testing) to specialized CROs, rather than using a single, i
- In-house R&D without Advanced Platform: Maintaining an in-house drug discovery program without adopting advanced integrated platforms, potentially leading to slower development cycles and higher costs
#### Buyers search for
- AbCellera antibody discovery platform
- AbCellera drug pipeline
- AbCellera careers Vancouver
- Specialized Computational Biology Software: Using individual software tools for specific aspects like protein modeling or sequence analysis, but lacking AbCellera's integrated biological and engineeri
### Links
- Canonical page: https://optimly.ai/brand/abcellera
- JSON endpoint: /brand/abcellera.json
- LLMs.txt: /brand/abcellera/llms.txt